New Studies Confirm Advantages of Blue Light Cystoscopy

Two new studies presented at the American Urological Association 2017 annual meeting clearly show that blue light cystoscopy offers a significant advantage over white light cystoscopy identifying bladder tumors, according to Gary Steinberg, MD, Professor of Surgery and Director of Urologic Oncology at the University of Chicago Medical Center. Dr. Steinberg has used blue light cystoscopy (Cysview) in the operating room since 2010, when it received FDA approval.

The technology has enabled him to identify tumors much more readily, especially in parts of the bladder that are difficult to visualize. Use of blue light cystoscopy has resulted in decreases in recurrence rates and changes in patient management.